David E. Arterburn, MD, MPH

David Arterburn

“It's critical that we find cost-effective ways to reduce obesity. My research examines the long-term effects of behavioral, pharmaceutical, and surgical treatments and promotes shared decision-making between patients and their providers.” 

David Arterburn, MD, MPH

Senior Investigator, Kaiser Permanente Washington Health Research Institute
Physician, Washington Permanente Medical Group, Internal Medicine

Biography

David Arterburn, MD, MPH, is a general internist and health services researcher who focuses on finding safe, effective, and innovative ways to treat obesity. As an international leader in obesity research, his goal is to help individuals and families make treatment decisions that align with their values while sustaining their health over the long haul.

Dr. Arterburn's research portfolio includes studies of the impact of neighborhood environments on obesity, behavioral and lifestyle interventions for weight loss, obesity pharmaco-epidemiology, the long-term outcomes of bariatric surgery, and shared decision making related to elective surgery. He recently led the PCORnet Bariatric Study, a two-year, $4.5 million study comparing the health benefits and safety associated with the main types of bariatric surgery in 41 health systems in the United States. Funded by the Patient-Centered Outcomes Research Institute (PCORI), the study’s results give patients and their health care providers the information they need to decide which type of surgery is best for them. In July 2019, PCORI awarded Dr. Arterburn an additional $2.1 million to incorporate these new results into shared decision making at Kaiser Permanente Washington and the University of Pittsburgh Medical Center.

Over the past decade, Dr. Arterburn has collaborated with Kaiser Permanente Washington's specialty leadership to implement and evaluate shared decision making with patient decision aids to support elective surgical care. The approach has shown great promise for improving the quality of health care while simultaneously lowering the costs of care in some populations.

Dr. Arterburn collaborates extensively in his research and has NIH-funded projects related to obesity and bariatric surgery with investigators at Kaiser Permanente, University of Washington (UW), Duke University, Harvard, University of Michigan, Wake Forest, and the Cleveland Clinic.

Dr. Arterburn joined Kaiser Permanente Washington Health Research Institute in 2006. In recognition of his contributions to science, he has been named an honorary Fellow of the American Society of Metabolic and Bariatric Surgery (FASMBS) and a Fellow of the American College of Physicians (FACP) and The Obesity Society (FTOS). Dr. Arterburn is past chair of the Adult Obesity Measurement Advisory Panel sponsored by the National Committee on Quality Assurance, founding chair of the Obesity Society's Health Services Research Section, and past chair of the Health Care Systems Research Network's Obesity Special Interest Group. In 2013 he co-chaired the National Institutes of Health Symposium on the Long-Term Outcomes of Bariatric Surgery. He is also an affiliate professor in the UW Department of Medicine.

Areas of research focus

Recent publications

Barthold D, Brouwer E, Barton LJ, Arterburn DE, Basu A, Courcoulas A, Crawford CL, Fedorka PN, Fischer H, Kim BB, Mun EC, Murali SB, Reynolds K, Yoon TK, Zane RE, Coleman KJ. Minimum threshold of bariatric surgical weight loss for initial diabetes remission. Diabetes Care. 2021 Sep 13:dc210714. doi: 10.2337/dc21-0714. [Epub ahead of print]. PubMed

Chao GF, Yang J, Thumma J, Chhabra KR, Arterburn DE, Ryan A, Telem DA, Dimick JB. Volume-outcome relationships for Roux-en-Y gastric bypass patients in the sleeve gastrectomy era. Surg Endosc. 2021 Sep 1. doi: 10.1007/s00464-021-08705-6. [Epub ahead of print]. PubMed

Arterburn D, Lewis KH. Different risks and benefits leading to similar costs after sleeve gastrectomy and Roux-en-Y gastric bypass. JAMA Netw Open. 2021;4(9):e2122541. doi: 10.1001/jamanetworkopen.2021.22541. PubMed

Buszkiewicz JH, Bobb JF, Kapos F, Hurvitz PM, Arterburn D, Moudon AV, Cook A, Mooney SJ, Cruz M, Gupta S, Lozano P, Rosenberg DE, Theis MK, Anau J, Drewnowski A. Differential associations of the built environment on weight gain by sex and race/ethnicity but not age. Int J Obes (Lond). 2021 Aug 27. doi: 10.1038/s41366-021-00937-9. [Epub ahead of print]. PubMed

Peskoe SB, Arterburn D, Coleman KJ, Herrinton LJ, Daniels MJ, Haneuse S. Adjusting for selection bias due to missing data in electronic health records-based research. Stat Methods Med Res. 2021 Aug 26:9622802211027601. doi: 10.1177/09622802211027601. [Epub ahead of print]. PubMed

 

New findings

Bariatric-Surgery-CKD-prevention_1col.jpg

Is bariatric surgery helpful in chronic kidney disease?

David Arterburn and colleagues find that bariatric surgery is linked to lower death risk in persons with obesity and CKD.

Research

urban setting apartments and skyscrapers obesity and the built environment

Built environment plays little role in weight gain

New research suggests fast food and other aspects of built environments don’t affect weight, contrary to earlier findings.

INNOVATIONS IN CARE

LHS-blog-stethascope-charts-1col.jpg

Helping KP Washington lead in intelligent health care

How our Learning Health System Program is using statistical methods and machine learning to respond to COVID-19.

KPWHRI In the Media

Best weight-loss surgery for diabetes and severe obesity?

Bariatric (weight-loss) surgery to treat type 2 diabetes

Diabetes Discovery & Practice Blog, Dec. 2, 2020